ZEB1 and neoplasm: Previous studies have demonstrated that miR-484 can reduce the expression of a series of oncogenes, such as ZEB1, SMAD2, etc., inhibit the epithelial-mesenchymal transition (EMT) of tumor cells, or regulate the extracellular signal-regulated kinase 1/2 signaling [16, 34, 38].